B, S. R. C., L, P. d. N., M, V. d. P. A., AP, B. G., & L, M. V. (2020). Stability of extemporaneous sulfadiazine oral suspensions from commercially available tablets for treatment of congenital toxoplasmosis. Tropical medicine & international health : TM & IH, 25(3), 364. https://doi.org/10.1111/tmi.13354
Chicago Style (17th ed.) CitationB, Soares Rodrigues Costa, Pontes do Nascimento L, Vítor de Paiva Amorim M, Barreto Gomes AP, and Mafra Veríssimo L. "Stability of Extemporaneous Sulfadiazine Oral Suspensions from Commercially Available Tablets for Treatment of Congenital Toxoplasmosis." Tropical Medicine & International Health : TM & IH 25, no. 3 (2020): 364. https://doi.org/10.1111/tmi.13354.
MLA (9th ed.) CitationB, Soares Rodrigues Costa, et al. "Stability of Extemporaneous Sulfadiazine Oral Suspensions from Commercially Available Tablets for Treatment of Congenital Toxoplasmosis." Tropical Medicine & International Health : TM & IH, vol. 25, no. 3, 2020, p. 364, https://doi.org/10.1111/tmi.13354.